FDA issued a Warning Letter to CardioCommand, Inc. on 8/13/2003 for a previous inspection.
483 Cardiocommand May 2017

483 Cardiocommand May 2017

Dianiris Ayala FDA$119.00 - Available Now

FDA investigators audited the Cardiocommand - Tampa, FL, United States facility and issued inspectional observations (via FDA 483) on 17 May 2017.

Product details

  • Category: Medical Devices & Rad Health
  • Inspection end: 17 May 2017
  • Location: Tampa, United States
  • FEI: 1927197
Add To Cart